AD-2281

N/A

Report date: 2025/01/09 20:00:05
NME

Base Information

Drug NameAD-2281
Drug Alias NameAD-2281
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypercholesterolemiaHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAddpharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAddpharma Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaHyperlipoproteinemia Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A